Rheumnow Podcast
VITAL Info on Autoimmune Disease (2.9.2024)
Feb 9, 2024
Dr. Jack Cush discusses the use of steroids in autoimmune diseases, disease activity in RA patients, telemedicine impact, fracture risk in CPPD disease, cancer risk in RA and AS patients, gout flare treatment with urea-lowering therapy, autoimmune disease prevention post VITAL trial, and skepticism towards vitamin D and omega-3 supplementation.
20:56
Episode guests
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- Ra patients struggle to taper off glucocorticoids despite advanced therapies.
- Obesity and ACPA positivity worsen disease activity in Rheumatoid Arthritis patients.
Deep dives
Steroid Use in Rheumatoid Arthritis Patients Under Advanced Therapies
A study of 228 rheumatoid arthritis (RA) patients revealed that despite being on targeted synthetics or biologic treatment, more than half of the patients were still taking glucocorticoids. Even after three years of using advanced therapies, 68% of the patients were still on very low dose glucocorticoids, indicating a lack of successful tapering. This study highlights the need for better strategies to discontinue steroid use in RA patients receiving advanced therapies.
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
